Immunohistochemical expression of RORγt, IL-23 and IL-1β can be easily accessed in routine pathology laboratories helping to predict the prognosis of patients with thyroid cancer and better individualize their clinical management. The gene discussed is IL1B; the disease is thyroid gland carcinoma.